El gobierno de Trump presentó un amplio paquete de propuestas regulatorias que cambiarían de manera sustancial la oferta de planes de salud en los mercados establecidos por la Ley de Cuidado de Salud a Bajo Precio (ACA) el próximo año. Según el gobierno, el objetivo es ofrecer más opciones y primas más bajas. Sin embargo,…
Health coverage enrollment through the Affordable Care Act (ACA) marketplaces now exceeds 24 million people, a dramatic increase in recent years fueled largely by enhanced premium aid, which started in 2021 as part of the American Rescue Plan Act and extended through 2025 under the Inflation Reduction Act. But, with the subsidies set to expire…More
Eli Lilly is paying up to $300 million for CrossBridge Bio, a startup developing antibody drug conjugates that deliver two drug payloads to cancers. Beyond potentially better efficacy, CrossBio’s dual approach could also fight drug resistance. The post Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors appeared first on…
The main question about health bots is accuracy and the trust or distrust that it engenders among users as a result. One journalist from the Washington Post and a strategic advisor to CMS had wildly differing experiences. The post WaPo Columnist and CMS Official Provide Dueling Narratives of ChatGPT Health appeared first on MedCity News.
Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group’s Optum subsidiary is hoping to change the dynamic through what they claim is a real-time claims management program leveraging tech. The post Is Optum Real For Real? appeared first on MedCity News.
The Plausible Mechanism Framework is a breakthrough. Turning it into treatments that reach families will take five things the framework doesn’t provide. The post The FDA Opened the Door For Rare Disease Patients — Here’s What It Takes to Walk Through It appeared first on MedCity News.
FDA’s January 2026 draft guidance on Bayesian methodology in drug and biologics trials signals a clear willingness to see Bayesian methods used for regulatory decisionmaking around clinical trials. The guidance lays out how sponsors (i.e., pharmaceutical manufacturers) should pre-specify priors, success criteria, and simulations so that Bayesian designs remain interpretable, control error rates when needed,…
As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly – and accurately – to improve their health and prognosis. The post Why Blood is Best: Transforming the Diagnostic Journey for Alzheimer’s…
Digital health engagement app Wellth raised $36 million in Series C funding to expand its “daily care motivation platform,” which uses small financial incentives and dopamine-driven nudges to keep patients engaged in healthy behaviors. The post Could Small Cash Prizes Motivate People to Be Healthier? Investors Say Yes appeared first on MedCity News.